Reported Jul 1, 2020 · Terminated
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe,…
QuVa Pharma, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: QuVa Pharma, Inc. · 1075 W Park One Dr Ste 100 · Sugar Land, TX · 77478-2576
Is this the product you have?
- R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350
- Lot codes and dates
- Lots
30008721Exp. 4/26/20203000819830008554Exp. 4/29/202030008861Exp. 4/30/202030008859Exp. 5/5/202030008949Exp. 5/10/202030009073Exp. 5/14/202030009074Exp. 30009138Exp. 5/17/20203000913930009227Exp. 5/19/202030009228Exp. 5/20/20203000938730009388Exp. 5/27/20203000941030009411Exp. 5/28/202030009413Exp. 5/31/20203000941230009489Exp. 6/1/20203000953930009563Exp. 6/3/2020
- Lots
- Amount recalled
- 17,050 syringes
Where it was sold
- Nationwide
Why it was recalled
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new QuVa Pharma, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.